{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "GBp", "regularMarketChangePercent": 1.6483545, "regularMarketPrice": 222.0, "earningsTimestamp": 1690956000, "earningsTimestampStart": 1690956000, "earningsTimestampEnd": 1690956000, "trailingAnnualDividendRate": 0.06, "trailingPE": 111.00001, "trailingAnnualDividendYield": 0.0002747253, "epsTrailingTwelveMonths": 0.02, "epsForward": 0.11, "epsCurrentYear": 0.1, "priceEpsCurrentYear": 2220.0, "sharesOutstanding": 2043869952, "bookValue": 0.792, "fiftyDayAverage": 221.688, "fiftyDayAverageChange": 0.31199646, "fiftyDayAverageChangePercent": 0.0014073674, "twoHundredDayAverage": 225.6165, "twoHundredDayAverageChange": -3.6165009, "twoHundredDayAverageChangePercent": -0.016029416, "marketCap": 4537391104, "forwardPE": 20.181818, "priceToBook": 280.30304, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.2 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1477465200000, "priceHint": 2, "marketState": "CLOSED", "exchange": "LSE", "shortName": "CONVATEC GROUP PLC ORD 10P", "longName": "ConvaTec Group PLC", "messageBoardId": "finmb_39347275", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "market": "gb_market", "esgPopulated": false, "regularMarketChange": 3.600006, "regularMarketTime": 1683913514, "regularMarketDayHigh": 223.4, "regularMarketDayRange": "217.6 - 223.4", "regularMarketDayLow": 217.6, "regularMarketVolume": 5492113, "regularMarketPreviousClose": 218.4, "bid": 221.8, "ask": 222.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "LSE", "financialCurrency": "USD", "regularMarketOpen": 220.0, "averageDailyVolume3Month": 6231989, "averageDailyVolume10Day": 7712895, "fiftyTwoWeekLowChange": 26.100006, "fiftyTwoWeekLowChangePercent": 0.13323128, "fiftyTwoWeekRange": "195.9 - 267.831", "fiftyTwoWeekHighChange": -45.830994, "fiftyTwoWeekHighChangePercent": -0.17111908, "fiftyTwoWeekLow": 195.9, "fiftyTwoWeekHigh": 267.831, "symbol": "CTEC.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "3 Forbury Place", "address2": "23 Forbury Road", "city": "Reading", "zip": "RG1 3JH", "country": "United Kingdom", "phone": "44 11 8952 8100", "website": "https://www.convatecgroup.com", "industry": "Medical Instruments & Supplies", "industryDisp": "Medical Instruments & Supplies", "sector": "Healthcare", "longBusinessSummary": "ConvaTec Group PLC engages in the development, manufacture, and marketing of medical products and technologies worldwide. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence and critical care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as Parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.", "fullTimeEmployees": 10036, "companyOfficers": [{"maxAge": 1, "name": "Mr. Karim  Bitar", "age": 57, "title": "CEO & Director", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": {"raw": 2447000, "fmt": "2.45M", "longFmt": "2,447,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jonathan P. Mason", "age": 58, "title": "Group CFO & Director", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 1061200, "fmt": "1.06M", "longFmt": "1,061,200"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John  Haller", "title": "Exec. VP and Chief Quality & Operations Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Divakar  Ramakrishnan Ph.D.", "title": "Exec. VP, Chief Technology Officer and Head of R&D", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Kate  Postans", "title": "VP of Investor Relations & Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Natalia  Kozmina", "title": "Exec. VP, Chief HR Officer & ESG Stewardship", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Christian  Hoengaard", "title": "Sr. VP & GM - USA", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Kjersti  Grimsrud Biotechnology, M.Sc.", "age": 61, "title": "Pres & COO of Infusion Care", "yearBorn": 1961, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Supratim  Bose", "age": 70, "title": "Pres & COO of Global Emerging Markets", "yearBorn": 1952, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. David  Shepherd", "title": "Pres & COO of Global Advanced Wound Care", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 4, "boardRisk": 4, "compensationRisk": 10, "shareHolderRightsRisk": 1, "overallRisk": 9, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}